Strategic Partners A/SCHIX:STRAPC 28 Altman Z-Score is 14.39 as of Jun. 25, 2026, which is 98% above its 10-year median of 7.26. GuruFocus rates CHIX:STRAPC with a GF Score™ of 28/100. Among 935 Biotechnology companies, Strategic Partners A/S ranks better than 82.78% on this metric.
The Altman Z-Score is a model designed to predict the likelihood of a company going bankrupt within the next two years. Created by American finance professor Edward Altman in 1968, the model is specifically designed for publicly traded manufacturing companies with assets greater than $1 million.
Good Sign:
Altman Z-score of 14.17 is strong.
Strategic Partners A/S has a Altman Z-Score of 14.39, indicating it is in Safe Zones. This implies the Altman Z-Score is strong.
The zones of discrimination were as such:
When Altman Z-Score <= 1.8, it is in Distress Zones.
When Altman Z-Score >= 3, it is in Safe Zones.
When Altman Z-Score is between 1.8 and 3, it is in Grey Zones.
The historical rank and industry rank for Strategic Partners A/S's Altman Z-Score or its related term are showing as below:
CHIX:STRAPc'
s Altman Z-Score Range Over the Past 10 Years
Min: -26.3 Med: 7.26 Max: 16.59
Current: 14.17
During the past 12 years, Strategic Partners A/S's highest Altman Z-Score was 16.59. The lowest was -26.30. And the median was 7.26.
X1: The Working Capital/Total Assets (WC/TA) ratio is a measure of the net liquid assets of the firm relative to the total capitalization. Working capital is defined as the difference between current assets and current liabilities. Ordinarily, a firm experiencing consistent operating losses will have shrinking current assets in relation to total assets. Altman found this one proved to be the most valuable liquidity ratio comparing with the current ratio and the quick ratio. This is however the least significant of the five factors.
X2: Retained Earnings/Total Assets: the RE/TA ratio measures the leverage of a firm. Retained earnings is the account which reports the total amount of reinvested earnings and/or losses of a firm over its entire life. Those firms with high RE, relative to TA, have financed their assets through retention of profits and have not utilized as much debt.
X3, Earnings Before Interest and Taxes/Total Assets (EBIT/TA): This ratio is a measure of the true productivity of the firm's assets, independent of any tax or leverage factors. Since a firm's ultimate existence is based on the earning power of its assets, this ratio appears to be particularly appropriate for studies dealing with corporate failure. This ratio continually outperforms other profitability measures, including cash flow.
X4, Market Value of Equity/Book Value of Total Liabilities (MVE/TL): The measure shows how much the firm's assets can decline in value (measured by market value of equity plus debt) before the liabilities exceed the assets and the firm becomes insolvent.
X5, Revenue/Total Assets (S/TA): The capital-turnover ratio is a standard financial ratio illustrating the sales generating ability of the firm's assets.
Altman Z-Score does not apply to financial companies.
Strategic Partners A/S Altman Z-Score Related Terms
Strategic Partners A/S Altman Z-Score Historical Data
* Premium members only.
The historical data trend for Strategic Partners A/S's Altman Z-Score can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CHIX:STRAPC vs VRTX, REGN, ALNY: Altman Z-Score Comparison
For the Biotechnology subindustry, Strategic Partners A/S's Altman Z-Score, along with its competitors' market caps and Altman Z-Score data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Strategic Partners A/S Altman Z-Score vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Strategic Partners A/S's Altman Z-Score distribution charts can be found below:
* The bar in red indicates where Strategic Partners A/S's Altman Z-Score falls into.
Altman Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency. GuruFocus does not calculate Altman Z-Score when X4 or X5 value is 0.
Strategic Partners A/S (CHIX:STRAPC) has a Altman Z-Score of 14.39 as of Jun. 25, 2026. The Altman Z-score measures a company's bankruptcy risk. View historical data on Strategic Partners A/S and its competitors. This is 98% above median its historical median of 7.26. According to the industry distribution chart, Strategic Partners A/S ranks #161 out of 935 companies in the Biotechnology industry, placing it in the top 17.2%.
Is Strategic Partners A/S's Altman Z-Score too high?
Strategic Partners A/S's current Altman Z-Score of 14.39 is 98% above median its 10-year median of 7.26. The Biotechnology industry median Altman Z-Score is 2.61. Strategic Partners A/S's value of 14.39 is 451.3% above this industry median. Based on the distribution chart, Strategic Partners A/S ranks #161 out of 935 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Strategic Partners A/S has a GF Score™ of 28/100, reflecting its overall financial health beyond just this single metric.
How does Strategic Partners A/S's Altman Z-Score compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Strategic Partners A/S ranks #161 out of 935 companies for Altman Z-Score. This places Strategic Partners A/S in the top 17% of its industry — outperforming the majority of peers. The industry median Altman Z-Score is 2.61. Strategic Partners A/S's value of 14.39 is 451.3% above this benchmark. While the company's 10-year median is 7.26 vs. the industry median of 2.61, Strategic Partners A/S has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Altman Z-Score for a Biotechnology company?
The median Altman Z-Score among Biotechnology companies is 2.61, based on 935 companies in the industry. Companies in the top quartile (top 25%) have a Altman Z-Score significantly above this median, while those in the bottom quartile fall well below. However, Altman Z-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Strategic Partners A/S's current Altman Z-Score of 14.39 is 451.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Altman Z-Score mean?
A high Altman Z-Score can signal that a stock is expensive relative to its fundamentals. The Altman Z-score measures a company's bankruptcy risk. View historical data on Strategic Partners A/S and its competitors. For the Biotechnology industry, the median Altman Z-Score is 2.61 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Strategic Partners A/S's current Altman Z-Score is 14.39, which is 98% above median its own 10-year median of 7.26. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Strategic Partners A/S stock overvalued right now?
Strategic Partners A/S (CHIX:STRAPC) has a current Altman Z-Score of 14.39. The current Altman Z-Score is 14.39, which is 98% above median its 10-year median of 7.26 and 451.3% above the Biotechnology industry median of 2.61. Strategic Partners A/S's overall GF Score™ is 28/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Altman Z-Score calculated?
Altman Z-Score is calculated from a company's financial statements. For Strategic Partners A/S (CHIX:STRAPC), the current Altman Z-Score is 14.39 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Strategic Partners A/S enters into strategic partnerships with companies with potential, where the company can take an active ownership and create value through its competencies. Additionally, the company takes part in other equity investments and properties, etc., to generate returns.
28GF Score
Get the complete analysis for CHIX:STRAPC
Altman Z-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHIX:STRAPC has been successfully added to your 
